Brewer Bans Syringe Services as Lewiston Votes on a 20-Syringe Cap

The Brewer City Council voted unanimously Tuesday to prohibit syringe service programs at both fixed and mobile locations, making the Penobscot County city the first in Maine to ban the programs outright rather than restrict how they operate. Six days from now, Lewiston voters will answer a narrower question: whether to cap exchanges at one needle for one needle, twenty syringes a day, and force every provider onto a single fixed site with no mobile units.

Both votes run against the direction state government has taken. Maine's public health agency replaced a strict one-for-one rule with a needs-based standard in 2022, and in 2025 the Legislature and Governor Janet Mills authorized mobile exchange sites. Brewer and Lewiston would pull that back city by city, through zoning and a citizen-initiated ordinance.

What the Brewer council actually passed

The change arrived as Order 2026-C027, filed October 13: an amendment to Chapter 24 of the city code, Section 306, "Schedule of Uses," the table governing what may be operated where. In a list of prohibited uses that already barred adult-use cannabis cultivation and medical marijuana retail stores, the order adds a line: "Needle exchange programs and/or services are prohibited for both mobile units and physical brick-and-mortar site locations."

The order's Statement of Fact calls the package "formatting and clarification on prohibited uses and permit processes," and says "there are currently no known needle exchange programs and/or services ... within the City of Brewer that would be impacted by these amendments." It records that the Planning Board held a public hearing on September 14, 2026, unanimously recommended adoption, and that "there were no public comments."

The council chamber was different. WABI reported residents speaking against the programs, several pointing across the Penobscot River to Bangor: "I think a service location could attract increased foot traffic, loitering, and public drug use. We've seen it all in Bangor." Public Safety Director Chris Martin said the nearest programs are in Bangor and Brewer is absorbing the consequences — "legitimate concerns for residents, family, children, pets, and the municipal employees responsible for maintaining our community." Mayor Jenn Morin said the council weighed the police chief's input and constituent conversations.

A zoning entry that drew no comment in September became, by late October, a public safety vote about a service Brewer does not have.

Lewiston's Question 1 would undo the state's one-to-one-plus rule

Lewiston's question is short enough to quote whole:

"Shall the city ordinance pertaining to the Lewiston Syringe Service Program be amended to mandate a strict 1:1 needle exchange with a 20-syringe daily limit per person, require each provider to operate from one fixed location, and prohibit all mobile exchange units?"

Lewiston now allows up to 100 clean syringes per visit, Maine Public reports. That is not local improvisation. Under the Maine CDC's rule, 10-144 CMR chapter 252, amended in 2022, a certified program may use a "1:1+" strategy: a client who arrives with nothing to return can still receive up to 100, at the site's discretion. The state report describing the change says it was meant to "remove barriers associated with a strict 1:1 exchange policy" and move toward needs-based exchange, which the CDC treats as best practice because it reduces needle sharing.

The mobile-unit piece is newer. Public Law 2025, chapter 408 (LD 1078) let certified programs run mobile sites inside the municipality where they are certified — rotating locations, variable schedules, temporary setups, delivery. The implementing rules took effect March 8, 2026. Question 1 would prohibit all of it.

One legal nuance matters. Section 1341 of Title 22 lets the Maine CDC limit how many syringes a program provides (a 2021 amendment) but bars the state from limiting how many participants "may legally possess, transport or exchange" (2007). Question 1 targets what the provider hands out, so its battlefield is the local ordinance, not the statute.

Portland rejected a similar measure two years ago, according to Maine Public. Lewiston would be the first city to pass one.

What Maine's own data says the programs do

The state reports annually under 22 M.R.S. § 1341(3). The 2025 edition, covering November 1, 2024, through October 31, 2025, is the best available counterweight to the needle-waste argument.

Maine's 10 certified programs — 17 sites in 11 of 16 counties — distributed 2,696,610 sterile syringes and collected and disposed of 2,483,916 used ones. They served 11,658 participants, enrolled 2,746 new ones, and made 51,909 referrals to medical care, HIV and hepatitis testing, treatment, peer support, overdose aftercare, wound care, housing and transportation. They ran 1,354 HIV tests and 418 hepatitis C tests, provided naloxone at 12,600 encounters, and handed out 28,814 xylazine and 36,862 fentanyl test kits.

That is about 5,000 used syringes collected each day, from a system that doubles as Maine's most consistent doorway to testing and treatment.

An outbreak that is still running

The report treats the disease question as live. It describes an HIV cluster recognized in Penobscot County in January 2024 among people who inject drugs, "primarily among individuals who are also currently or recently unhoused," with hepatitis C co-infection. As of December 1, 2025, 31 people newly diagnosed with HIV were tied to the outbreak; 30 were co-infected with hepatitis C. The CDC sent on-site technical assistance in August and December 2025. The state's conclusion is blunt: local programs "have been critical in reaching the affected population," and "when these services are disrupted, the state's ability to respond effectively to outbreaks is significantly impacted."

Brewer sits across the river from that county's largest city.

Zoning is already the operative lever there. The report notes Needlepoint Sanctuary in Bangor temporarily closed in 2025 "to ensure compliance with local zoning policies" and reopened permanently in November. Health Equity Alliance and the Church of Safe Injection were decertified during the year, closing four locations; Spurwink covered the gap in Lewiston. Three new organizations opened sites in Augusta, Rockland and Deer Isle.

Why the timing cuts both ways

Maine's overdose picture is improving slowly. The University of Maine's monthly report for August 2026 counts 249 confirmed and suspected fatal overdoses from January through August, 5.7 percent below the 264 in the same months of 2025. Reported nonfatal overdoses rose from 4,739 to 5,045.

One category inside those numbers is growing fast: community reversals with naloxone, meaning overdoses reversed by bystanders or outreach workers rather than EMS or police. They accounted for 1,097 reports in the first eight months of 2026 — 20.7 percent of all nonfatal overdoses — against 1,010 a year earlier, including 253 in August alone. Syringe programs are one distribution channel for that naloxone; the 2025 report counts naloxone at 12,600 encounters.

Funding is a patchwork: about $75,000 a year in state money divided across all exchanges under a 2017 law, federal grants, and, since late 2024, $75,000 annually per site for two years from the Maine Recovery Council, which directs the state's opioid settlement share.

What to watch on November 3

Lewiston votes Tuesday. If Question 1 passes, Spurwink's site must move to one fixed location, drop any mobile operation, and enforce a 20-syringe daily ceiling — the opposite of the discretionary 100-syringe standard. If it fails, whether a municipality can restrict a state-certified program through its own ordinance stays untested in court, though Brewer has answered the zoning version locally.

Two things to watch beyond the count: whether Brewer's ban is challenged or becomes a template (Bangor weighed a six-month ban earlier this year), and whether the next state report records a change in Androscoggin or Penobscot distributions. It tracks syringes site by site, so any interruption shows up within a year.

For families the practical question is narrower. If a program near you closes or shortens its hours, the supplies it handed out — naloxone, test strips, wound care — do not vanish, they get harder to find. Naloxone is available without a prescription at most Maine pharmacies, and test strips are still legal even where exchange sites are restricted. The infections these programs exist to prevent are treatable regardless of where syringes come from; Maine's whole-person care waiver is the separate Medicaid thread to follow.

If you need help now

The SAMHSA National Helpline, 1-800-662-4357, is free, runs 24 hours a day in English and Spanish, and refers callers to sliding-scale treatment anywhere in Maine. The 988 Suicide and Crisis Lifeline handles substance-related crises by call or text. FindTreatment.gov lists licensed programs by ZIP code, including medication for opioid use disorder. If someone is unresponsive or breathing slowly after using drugs, call 911 — Maine's Good Samaritan law protects the caller.